FDA Requires Boxed Warning for Promethazine Hydrochloride Inject...

Courtesy Food and Drug Administration--Recalls  Wed, 09/16/2009 - 09:48

The U.S. Food and Drug Administration is telling manufacturers of the drug promethazine to include a boxed warning regarding the injectable form of the drug.

The warning, under FDA’s authority to require safety labeling changes, will highlight the risk of serious tissue injury when this drug is administered incorrectly.

The agency is also alerting health care professionals to the new boxed warning for this product, which is used as a sedative and to treat nausea and vomiting.

Tags:

 

More related items

FDA Alert: New USP Standards for Heparin Products...
The U.S. Food and Drug Administration today alerted health care professionals to a change in heparin manufacturing that is expected to decrease the potency of the common blood-clotting drug.

FDA Alerts Public about Danger of Skin Numbing...
The U.S. Food and Drug Administration today issued a Public Health Advisory to alert consumers, patients, health care professionals, and caregivers about potentially serious and...

FDA Advises Patients to Switch to HFA-Propelled...
The U.S. Food and Drug Administration issued a public health advisory to alert patients, caregivers and health care professionals to switch to hydrofluoroalkane (HFA)-propelled albuterol...

Nature Made Maximum Strength Omega-3 Fish Oil 1,200...
Consumption of Omega-3 fatty acids may reduce the risk of coronary heart disease. FDA evaluated the data and determined that although there is scientific evidence supporting the claim, the...

Schiff Melatonin Plus 3 mg Melatonin with 25 mg...
Melatonin is a metabolic hormone made in the pineal gland, retina, and intestines. Melatonin is released into the blood stream by the pineal gland (which resides in the brain) to set your...


 

Post new comment

The content of this field is kept private and will not be shown publicly.
health-fitness.marc8.com